People with type 2 diabetes taking SGLT2 inhibitors can remain at risk of ketoacidosis throughout treatment, with certain patient characteristics associated with substantially higher risk, a ...
MiniMed’s first app-controlled insulin pump has received CE Mark in Europe, bringing the company’s smallest pump design to people living with insulin-treated diabetes across the continent. The ...
Watch now: Diabetes Times Editor Oliver Jelley speaks with Pete Revell, Head of Marketing and Fundraising at the National Kidney Federation (NKF), for the latest Big Interview. Pete discusses CKD ...
A national survey has been launched to assess the quality and safety of inpatient diabetes care and understand the impact of diabetes care on patients across NHS trusts in England. The Getting It ...